Top Markets
#1 Purr Purr +56.44%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +49.99%
#4 Non-Playable Coin Non-Playable Coin +31.31%
#5 Kinetiq Kinetiq +26.80%
#6 StonkBroker StonkBroker +26.42%
#7 ApeX ApeX +24.48%
#8 Morpho Morpho +22.27%
#9 TENDIES TENDIES +21.98%
#10 OriginTrail OriginTrail +21.44%
Coin of the day
Purr Purr
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Kinnate Biopharma Inc. Kinnate Biopharma Inc.

Kinnate Biopharma Inc.

KNTE
Pozycja w akcjach #21072
Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily... Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily focused on identifying and advancing small-molecule drugs that target kinase enzymes to treat cancers defined by specific genetic markers. The company's product pipeline includes: KIN-2787: An inhibitor of rapidly accelerated fibrosarcoma (RAF), currently being developed to treat patients with lung cancer, melanoma, and other forms of solid tumors. KIN-3248: A small-molecule kinase inhibitor designed to counteract cancer-associated genetic mutations in the fibroblast growth factor receptors, specifically FGFR2 and FGFR3. KIN004 Program: This program encompasses early-stage small-molecule research, including a Cyclin-Dependent Kinase 12 (CDK12) inhibitor. Established in 2018, Kinnate Biopharma Inc. maintains its headquarters in San Francisco, California. It was formerly a division of Fount Therapeutics, LLC.
Cena akcji
$2.65
Ostatnia synchronizacja: 2024-04-03
Kapitalizacja rynkowa
$115.71M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Kinnate Biopharma Inc. (KNTE)

Kategoria

Healthcare
Historia ceny akcji dla Kinnate Biopharma Inc. (KNTE)
Najwyższa cena zamknięcia: $2.65 dnia 2024-04-01

Najniższa cena zamknięcia: $40.13 dnia 2020-12-01
Historia cen akcji firmy Kinnate Biopharma Inc. od 2020 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 15.54%
2023 -63.61%
2022 -64.96%
2021 -55.12%
2020 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH